Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis

Clinical Science

Volumn 105, Issue 3, 2003, Pages 373-382

  Lichtinghagen, Ralf ^a   Bahr, Matthias J ^b   Wehmeier, Michael ^a,b   Michels, Dirk ^a,b   Haberkorn, Christian I ^a,b   Arndt, Burkhard ^a   Flemming, Peer ^b   Manns, Michael P ^b   Boeker, Klaus H W ^b  

^a UNIVERSITY OF APPLIED SCIENCES AND ARTS   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cirrhosis; Fibrogenesis; Hepatitis C; Matrix remodelling; Metalloproteinase (MMP); Tissue inhibitor of metalloproteinases (TIMP)

Indexed keywords

COLLAGENASE 3; ENZYME PRECURSOR; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; STROMELYSIN; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; GENE IDENTIFICATION; GENETIC POLYMORPHISM; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CASE-CONTROL STUDIES; ENZYME PRECURSORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASES; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC;

EID: 0042877150     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20030098     Document Type: Article

References (45)

1. Burt, A. D. (1999) Pathobiology of hepatic stellate cells. J. Gastroenterol. 34, 299-304
2. Gressner, A. M. (1996) Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis. Kidney Int. Suppl. 54, S39-45
3. Li, D. and Friedman, S. L. (1999) Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J. Gastroenterol. Hepatol. 14, 618-633
4. Olaso, E. and Friedman, S. L. (1998) Molecular regulation of hepatic fibrogenesis. J. Hepatol. 29, 836-847
5. Nagase, H. and Woessner, Jr, J. F. (1999) Matrix metalloproteinases. J. Biol. Chem. 274, 21491-21494
6. Brinckerhoff, C. E. and Matrisian, L. M. (2002) Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell. Biol. 3, 207-214
7. Gomez, D. E., Alonso, D. F., Yoshiji, H. and Thorgeirsson, U. P. (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74, 111-122
8. Brew, K., Dinakarpandian, D. and Nagase, H. (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta 1477, 267-283
9. Arthur, M. J. P. (1995) Collagenases and liver fibrosis. J. Hepatol. 22, 43-48
10. Arthur, M. J. P. (1997) Matrix degradation in liver: a role in injury and repair. Hepatology 26, 1069-1071
11. Herbst, H., Heinrichs, O., Schuppan, D., Milani, S. and Stein, H. (1991) Temporal and spatial patterns of transin/stromelysin RNA expression following toxic injury in rat liver. Virchows Arch. B: 60, 295-300
12. Yata, Y., Takahara, T., Furui, K., Zhang, L. P. and Watanabe, A. (1999) Expression of matrix metalloproteinase-13 and tissue inhibitor of metalloproteinase-1 in acute liver injury. J. Hepatol. 30, 419-424
13. Kossakowska, A. E., Edwards, D. R., Lee, S. S. et al. (1998) Altered balance between matrix metalloproteinases and their inhibitors in experimental billary fibrosis. Am. J. Pathol. 153, 1895-1902
14. Benyon, R. C., Iredale, J. P., Goddard, S., Winwood, P. J. and Arthur, M. J. P. (1996) Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology 110, 821-831
15. Milani, S., Herbst, H., Schuppan, D. et al. (1994) Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am. J. Pathol. 144, 528-537
16. Herbst, H., Wege, T., Milani, S. et al. (1997) Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am. J. Pathol. 150, 1647-1659
17. Lichtinghagen, R., Michels, D., Haberkorn, C. I. et al. (2001) Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C. J. Hepatol. 34, 239-247
18. Lichtinghagen, R., Steinmetz, C., Pehle, B., Breitenstein, K., Seifert, T. and Boeker, K. H. W. (1999) Matrix metalloproteinases in liver and serum in chronic active hepatitis C and HCV-induced cirrhosis. Hepatol. Res. 14, 119-134
19. Ishak, K., Baptista, A., Bianchi, L. et al. (1995) Histological grading and staging of chronic hepatitis. J. Hepatol. 22, 696-699
20. Lein, M., Nowak, L., Jung, K. et al. (1997) Analytical aspects regarding the measurement of metalloproteinases and their inhibitors in blood. Clin. Biochem. 30, 491-496
21. Jung, K., Laube, C., Lein, M. et al. (1998) Kind of sample as preanalytical determinant of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood. Clin. Chem. 44, 1060-1062
22. Trummer, A., Kadar, J., Arseniev, L., Petersen, D., Ganser, A. and Lichtinghagen, R. (2000) Competitive cytokeratin 19 RT-PCR for quantification of breast cancer cells in blood cell suspensions. J. Hematother. Stem Cell Res. 9, 275-284
23. Lichtinghagen, R., Helmbrecht, T., Arndt, B. and Böker, K. H. W. (1995) Expression pattern of matrix metalloproteinases in human liver. Eur. J. Clin. Chem. Clin. Biochem. 33, 65-71
24. Lichtinghagen, R., Huegel, O., Seifert, T. et al. (2000) Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C. Clin. Chem. 46, 183-192
25. Ye, S., Watts, G. F., Mandalia, S., Humphries, S. E. and Henney, A. M. (1995) Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br. Heart J. 73, 209-215
26. Lichtinghagen, R., Diedrich-Glaubitz, R. and von Horsten, B. (1994) Identification of Bordetella pertussis in nasopharyngeal swabs using the polymerase chain reaction: evaluation of detection methods. Eur. J. Clin. Chem. Clin. Biochem. 32, 161-167
27. Kirkwood, B. R. (1981) Chi-square test for contingency tables. Br. J. Hosp. Med. 25, 291-292
28. Okazaki, I. and Maruyama, K. (1974) Collagenase activity in experimental hepatic fibrosis. Nature (London) 252, 49-50
29. Montfort, I. and Perez-Tamayo, R. (1978) Collagenase in experimental carbon tetrachloride cirrhosis of the liver. Am. J. Pathol. 92, 411-420
30. Maruyama, K., Feinman, L., Fainsilber, Z., Nakano, M., Okazaki, I. and Lieber, C. S. (1982) Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis. Life Sci. 30, 1379-1384
31. Perez-Tamayo, R., Montfort, I. and Gonzalez, E. (1987) Collagenolytic activity in experimental cirrhosis of the liver. Exp. Mol. Pathol. 47, 300-308
32. Iredale, J. P., Benyon, R. C., Arthur, M. J. P. et al. (1996) Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 24, 176-184
33. Iredale, J. P., Murphy, G., Hembry, R. M., Friedman, S. L. and Arthur, M. J. P. (1992) Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver. J. Clin. Invest. 90, 282-287
34. Takahara, T., Furui, K., Funaki, J. et al. (1995) Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats. Hepatology 21, 787-795
35. Takahara, T., Furui, K., Yata, Y. et al. (1997) Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers. Hepatology 26, 1521-1529
36. Carloni, V., Romanelli, R. G., Pinzani, M., Laffi, G. and Gentilini, P. (1997) Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. Gastroenterology 112, 522-531
37. Friedman, S. L. (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275, 2247-2250
38. Dufour, J. F., DeLellis, R. and Kaplan, M. M. (1998) Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment. Dig. Dis. Sci. 43, 2573-2576
39. Sobesky, R., Mathurin, P., Charlotte, F. et al. (1999) Modeling the impact of interferon α treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group. Gastroenterology 116, 378-386
40. Iredale, J. P., Goddard, S., Murphy, G., Benyon, R. C. and Arthur, M. J. P. (1995) Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin. Sci. 89, 75-81
41. Benyon, R. C., Hovell, C. J., Da Gaca, M., Jones, E. H., Iredale, J. P. and Arthur, M.J.P. (1999) Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation. Hepatology 30, 977-986
42. Geisler, S., Lichtinghagen, R., Böker, K. H. W. and Veh, R. W. (1997) Differential distribution of five members of the matrix metalloproteinase family and one inhibitor (TIMP-1) in human liver and skin. Cell Tissue Res. 289, 173-183
43. Boeker, K. H. W., Haberkorn, C. I., Michels, D. et al. (2002) Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C. Clin. Chim. Acta 316, 71-81
44. Murawaki, Y., Yamada, S., Ikuta, Y. et al. (1999) Clinical usefulness of serum matrix metalloproteinase-2 concentration in patients with chronic viral liver disease. J. Hepatol. 30, 1090-1098
45. Kasahara, A., Hayashi, N., Mochizuki, K. et al. (1997) Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. J. Hepatol. 26, 574-583